Jean-Yves Madec

Dr. Jean-Yves Madec


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
Jean-Yves MadecJean-Yves Madec
Jean-Yves Madec
MHM. Haenni
M. Haenni
PNP. Nordmann
P. Nordmann
LPL. Poirel
L. Poirel

1 March 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
MHMarisa Haenni
Marisa Haenni
LPLaurent Poirel
Laurent Poirel
NKNicolas Kieffer
Nicolas Kieffer
PCPierre Châtre
Pierre Châtre
ESEstelle Saras
Estelle Saras
Jean-Yves MadecJean-Yves Madec
Jean-Yves Madec

12 July 2013 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SDSafia Dahmen
Safia Dahmen
MHMarisa Haenni
Marisa Haenni
PCPierre Châtre
Pierre Châtre
Jean-Yves MadecJean-Yves Madec
Jean-Yves Madec
To characterize blaCTX-M IncFII plasmids and clones of Escherichia coli from cats and dogs and to compare them with blaCTX-M IncFII plasmids reported in humans. From December 2006 to April 2010, 518 E. coli isolates from clinical infections in cats and dogs were screened for extended-spectrum β-lactamase (ESBL) production. Antimicrobial susceptibility was performed by disc diffusion and resistance genes were identified by PCR and sequencing. Plasmids were characterized using PCR-based replicon typing and sub-typing schemes, restriction fragment length polymorphism analysis, S1-PFGE and Southern hybridization. Isolates were characterized by PFGE, phylogenetic grouping, O25b typing and multilocus sequence typing. Nineteen E. coli isolates (3.7%) produced ESBLs, of which 14 (74%) carried blaCTX-M IncFII plasmids. The blaCTX-M-15 gene was predominant and located on F31:A4:B1, F36:A4:B1 or F36:A1:B20 plasmids, abundantly reported in humans. The blaCTX-M-15 F22:A1:B20 or F2:A2:B20 plasmids were also found. Different sequence types (STs) were identified, such as ST10, ST410, ST359, ST617 and ST224. Only one E. coli isolate belonged to the ST131 E. coli clone and carried a blaCTX-M-14 F2:A2:B20 plasmid. This is the first known extensive study on ESBL-producing E. coli isolates from pets in France. The ST131 clone was rare. However, the predominance of human-like blaCTX-M-15 IncFII plasmids suggests exchanges of these plasmids with the human reservoir.

1 January 2015 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
HMHaenni Marisa
Haenni Marisa
DHDidier Hocquet
Didier Hocquet
CPCécile Ponsin
Cécile Ponsin
PCPascal Cholley
Pascal Cholley
CHRISTOPHE GUYEUXCHRISTOPHE GUYEUX
CHRISTOPHE GUYEUX
XBXavier Bertrand
Xavier Bertrand
Pseudomonas aeruginosa is a major human pathogen, which also affects animals. It is thought that P. aeruginosa has a non-clonal epidemic population structure, with distinct isolates found in humans, animals or the environment. However, very little is known about the structure of the P. aeruginosa population from diseased animals. Data on antimicrobial resistance are also scarce. Thirty-four already registered and 19 new MLST profiles were identified. Interestingly, a few clones were more prevalent, and clones associated to human outbreaks were also detected. Multidrug resistance phenotypes were overall rare. We highlight the non clonal structure of the population and show a higher prevalence of specific clones, possibly correlating with higher pathogenicity. The low proportion of antimicrobial resistance contrasts with the high resistance rate of human isolates.

29 December 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
Jean-Yves MadecJean-Yves Madec
Jean-Yves Madec
LPLaurent Poirel
Laurent Poirel
ESEstelle Saras
Estelle Saras
AGAurore Gourguechon
Aurore Gourguechon
DGDelphine Girlich
Delphine Girlich
MHMarisa Haenni
Marisa Haenni
To characterize blaCTX-M-15-carrying plasmids and lineages of nine strains of Escherichia coli from cattle. Plasmid DNA was analysed using PCR-based replicon typing and plasmid sub-typing schemes, restriction fragment length polymorphism, S1 nuclease-PFGE and Southern hybridization. Strains were characterized by PFGE, multilocus sequence typing, phylogenetic grouping and B2-O25b:H4-ST131 (where ST stands for sequence type) clone screening. Susceptibilities to antimicrobials were determined by agar diffusion and resistance genes were characterized by PCR and sequencing. The blaCTX-M-15 gene was found on F31:A4:B1/IncFII and F2:A–:B–/IncFII plasmids, which have been reported abundantly in humans. On F31:A4:B1/IncFII plasmids, the blaCTX-M-15 gene was associated with the blaTEM-1, blaOXA-1 and aac(6′)-Ib-cr resistance genes. The blaCTX-M-15 gene was also found on IncI1 plasmids of the CC31 clonal complex, recently identified in the human epidemic and virulent E. coli clone O104:H4. None of the cattle isolates belonged to the human and widespread clone B2-O25b:H4/ST131, but were mostly of new STs and of the phylogenetic groups A (n = 4), B1 (n = 3) or D (n = 2). The E. coli isolates harbouring the blaCTX-M-15-carrying plasmids were genetically diverse, and were recovered from different geographical locations and farms and at different times. This study demonstrates that blaCTX-M-15-carrying plasmids from cattle-derived non-ST131 E. coli isolates were highly similar to those found in ST131 E. coli isolates commonly reported in humans. It also exemplifies the key role of plasmids versus clonal dissemination in the spread of the blaCTX-M-15 gene among cattle, and possibly between E. coli isolates detected in humans and cattle.

10 May 2016 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
LYLydia Yaici
Lydia Yaici
MHMarisa Haenni
Marisa Haenni
ESEstelle Saras
Estelle Saras
WBWafa Boudehouche
Wafa Boudehouche
ATAbdelaziz Touati
Abdelaziz Touati
Jean-Yves MadecJean-Yves Madec
Jean-Yves Madec